
This section was prepared on the basis of five financial-data metrics from the 2025 Business Report (under K-IFRS, consolidated and separate), in alignment with GRI 201 and 207, ESRS 2 SBM-1 and SBM-2, IFRS S1 and S2, and K-IFRS. In accordance with the comparability principle of ESRS 1 (7.1), all quantitative indicators are disclosed in a three-year comparative format covering 2023, 2024, and 2025. The reporting boundary is i-SENS, Inc. plus 12 consolidated subsidiaries (consolidated basis) or i-SENS, Inc. on a standalone basis (separate basis). Qualitative financial policies and risks are disclosed in conjunction with the "ESG Management" section and with the separately filed Business Report (DART).
Fiscal Year 2025 recorded an all-time-high revenue of KRW 315.4 billion on a consolidated basis (+8.3%), and operating profit returned to positive territory, rising from KRW 2.66 billion to KRW 7.89 billion (+196.7%). However, due to the burden of large-scale investments such as the expansion of the Continuous Glucose Monitoring (CGM) line at the Songdo No. 2 Plant and the EU CGM launch marketing, net income for the period recorded a loss of KRW โ6.69 billion. This is regarded as a temporary cost burden until the effect of the 2027 CGM production capacity expansion to 5.4 million units takes full effect.
Unit: KRW million ยท Source: K-IFRS consolidated financial statements
Item | End of 2023 | End of 2024 | End of 2025 | YoY (2024 โ 2025) |
Total assets | 498,816 | 590,868 | 577,663 | โ2.2% |
Total liabilities | 195,321 | 247,887 | 239,342 | โ3.4% |
Total equity | 303,495 | 342,981 | 338,321 | โ1.4% |
Retained earnings | 211,577 | 208,192 | 198,775 | โ4.5% |
Unit: KRW million ยท Parentheses indicate negative figures
Item | 2023 | 2024 | 2025 | YoY (2024 โ 2025) |
Revenue | 265,120 | 291,138 | 315,445 | +8.3% |
Gross profit | 106,059 | 113,534 | 125,261 | +10.3% |
Operating profit | 10,929 | 2,658 | 7,887 | +196.7% |
Net income for the period | 3,404 | (1,953) | (6,691) | Loss widened |
Indicator | Formula | 2023 | 2024 | 2025 | YoY |
Gross profit margin | Gross profit / Revenue | 40.0% | 39.0% | 39.7% | +0.7%p |
Operating profit margin | Operating profit / Revenue | 4.1% | 0.9% | 2.5% | +1.6%p |
Debt-to-equity ratio | Liabilities / Equity | 64.4% | 72.3% | 70.7% | โ1.6%p |
Equity ratio | Equity / Assets | 60.8% | 58.0% | 58.6% | +0.6%p |
Unit: KRW million
Item | End of 2023 | End of 2024 | End of 2025 | YoY |
Total assets | 452,683 | 547,753 | 535,271 | โ2.3% |
Total liabilities | 164,646 | 216,027 | 211,032 | โ2.3% |
Total equity | 288,038 | 331,726 | 324,239 | โ2.3% |
Retained earnings | 209,233 | 209,167 | 201,575 | โ3.6% |
Unit: KRW million
Item | 2023 | 2024 | 2025 | YoY |
Revenue | 210,653 | 214,023 | 239,059 | +11.7% |
Gross profit | 72,435 | 72,390 | 75,238 | +3.9% |
Operating profit | 15,602 | 12,657 | 6,801 | โ46.3% |
Net income for the period | 1,078 | 1,525 | (3,324) | Turned to loss |
Item | 2023 | 2024 | 2025 | YoY (2024 โ 2025) |
Tax reductions and credits (KRW) | 1,244,311,879 | 2,547,903,265 | 1,274,936,240 | โ |
i-SENS, Inc. complies with the Framework Act on National Taxes, the Corporate Tax Act, the Restriction of Special Taxation Act, the Adjustment of International Taxes Act, and the OECD BEPS recommendations. In accordance with the Integrity Management Ethics Charter, the Company prohibits aggressive tax avoidance, transfer-pricing manipulation, and the use of tax havens. The country-by-country subsidiaries (10 entities) declare and pay lawful taxes under the tax laws of each jurisdiction, and intra-group transactions in the major markets of Korea, the United States, China, and the European Union apply arm's-length pricing in accordance with the OECD Arm's Length Principle.
The Fiscal Year 2025 country-by-country tax information (revenue, pre-tax profit, taxes paid, statutory tax rate, effective tax rate, and number of employees) is integrated and disclosed in the 2025 Business Report (DART filing). On this page, country-by-country separate disclosure will be reflected in the next update after finalization by the Finance Team immediately prior to publication.
EDM ID | Content | GRI | ESRS | IFRS S | Regulatory Alignment |
EC1-1 | Financial performance (consolidated and separate) | 201-1 | 2 SBM-1 | S1 General Disclosures | K-IFRS ยท DART |
EC1-2 | Government financial assistance | 201-4 | โ | โ | Restriction of Special Taxation Act |
EC1-3 | Country-by-country government financial assistance | 201-4 | โ | โ | โ |
EC2-1 | Tax policy | 207-1, 207-2, 207-3 | G1 (Business Conduct) | โ | OECD BEPS |
EC2-2 | Country-by-country tax information | 207-4 | โ | โ | OECD CbCR |
Area | Key KPI | 2023 | 2024 | 2025 | YoY (2024 โ 2025) | Global Alignment |
Revenue (consolidated) | Revenue (KRW 100 million) | 2,651 | 2,911 | 3,154 | +8.3% | GRI 201-1 |
Revenue (separate) | Revenue (KRW 100 million) | 2,107 | 2,140 | 2,391 | +11.7% | GRI 201-1 |
Gross profit (consolidated) | Gross profit (KRW 100 million) | 1,061 | 1,135 | 1,253 | +10.3% | GRI 201-1 |
Gross profit margin (consolidated) | % | 40.0% | 39.0% | 39.7% | +0.7%p | GRI 201-1 |
Operating profit (consolidated) | KRW 100 million | 109 | 27 | 79 | +196.7% | GRI 201-1 |
Operating profit margin (consolidated) | % | 4.1% | 0.9% | 2.5% | +1.6%p | GRI 201-1 |
Net income for the period (consolidated) | KRW 100 million | 34 | (20) | (67) | Loss widened | GRI 201-1 |
Financial soundness | Debt-to-equity ratio (consolidated) | 64.4% | 72.3% | 70.7% | โ1.6%p | K-IFRS |
Financial soundness | Equity ratio (consolidated) | 60.8% | 58.0% | 58.6% | +0.6%p | K-IFRS |
R&D investment | R&D expense (KRW 100 million) | 277 | 310 | 331 | +6.8% | GRI 201-1 |
R&D ratio | R&D / Revenue (%) | 10.4% | 10.6% | 10.5% | โ0.1%p | GRI 201-1 |
Government support | Tax reductions and credits (KRW 100 million) | 12.4 | 25.5 | 12.7 | โ | GRI 201-4 |
Tax governance | Tax avoidance / transfer-pricing violations | 0 cases | 0 cases | 0 cases | Maintained | GRI 207 ยท OECD BEPS |